Picture of Proteomics International Laboratories logo

PIQ — Proteomics International Laboratories News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Proteomics International Laboratories Says Signed A Licence Agreement

Dec 20 (Reuters) - Proteomics International Laboratories
Ltd  PIQ.AX :
    * SIGNED A LICENCE AGREEMENT FOR SALE OF PROMARKERD
PREDICTIVE
TEST FOR DIABETIC KIDNEY DISEASE IN CHILE
    * DEAL EXPANDS LONG-STANDING PARTNERSHIP WITH BIOTECHNOLOGY
COMPANY OMICS GLOBAL SOLUTIONS

Source text for Eikon:  ID:nASX271vlf 
Further company coverage:  PIQ.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Proteomics International Laboratories

See all news